Image of Atorvastatin:  A Review of its Use in the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus

LITERATURE

Atorvastatin: A Review of its Use in the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus


Atorvastatin (Lipitor®) is an HMG-CoA reductase inhibitor with well documented lipid-lowering effects. It has recently been evaluated for the primary prevention of major cardiovascular events in patients with type 2 diabetes mellitus without elevated serum low-density lipoprotein (LDL)-cholesterol levels.


Availability

Stator-001Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Drugs 2005; 65 (1): 137-152
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous